![]() |
Volumn 35, Issue 6, 1987, Pages 619-626
|
Plasma concentrations of 3-keto-desogestrel after oral administration of desogestrel and intravenous administration of 3-keto-desogestrel
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DESOGESTREL;
DESOGESTREL PLUS ETHINYLESTRADIOL;
ETHINYLESTRADIOL;
ORAL CONTRACEPTIVE AGENT;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED STUDY;
DIAGNOSIS;
DRUG BLOOD LEVEL;
DRUG THERAPY;
FEMALE GENITAL SYSTEM;
HUMAN;
PRIORITY JOURNAL;
THERAPY;
BIOLOGY;
CLINICAL RESEARCH;
CONTRACEPTION;
CONTRACEPTIVE AGENTS, FEMALE;
CONTRACEPTIVE AGENTS, PROGESTIN--PHARMACODYNAMICS;
CONTRACEPTIVE AGENTS--PHARMACODYNAMICS;
CONTRACEPTIVE METHODS;
DEVELOPED COUNTRIES;
ECONOMIC FACTORS;
ENDOCRINE SYSTEM;
ENGLAND;
EUROPE;
FAMILY PLANNING;
HEMIC SYSTEM;
HORMONES;
NORTHERN EUROPE;
ORAL CONTRACEPTIVES;
PHYSIOLOGY;
REPRODUCTIVE CONTROL AGENTS;
RESEARCH AND DEVELOPMENT;
RESEARCH METHODOLOGY;
TECHNOLOGY;
UNITED KINGDOM;
ADMINISTRATION, ORAL;
ADULT;
BIOLOGICAL AVAILABILITY;
DESOGESTREL;
ETHINYL ESTRADIOL;
FEMALE;
HUMAN;
INJECTIONS, INTRAVENOUS;
KINETICS;
NORPREGNENES;
|
EID: 0023202839
PISSN: 00107824
EISSN: None
Source Type: Journal
DOI: 10.1016/S0010-7824(87)80021-5 Document Type: Article |
Times cited : (49)
|
References (12)
|